Results 101 to 110 of about 194,403 (293)
Prognostic Impact of Late Gadolinium Enhancement on Major Adverse Cardiovascular Events and Time-Varying Attenuation of Risk in Dilated Cardiomyopathy. [PDF]
Clin CardiolIn 173 dilated cardiomyopathy patients, late gadolinium enhancement (LGE) independently predicted major adverse cardiovascular events, but its risk effect attenuated over ~34 months, while LVEDVi maintained stable long‐term prediction. Early CMR‐based risk stratification identifies a critical time window for intervention.
Ma L +6 more
europepmc +2 more sources
Dilated Cardiomyopathy in Pregnancy: A Review of ACEI Exposure and Fetal Risks [PDF]
Dilated cardiomyopathy (DCM) is a rare disease that can lead to serious cardiac complications, especially during pregnancy. In this study, a case of DCM in an advanced pregnancy with no known history of the disease resulting in spontaneous delivery is ...
Yakup Alsancak +3 more
core +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli +17 more
wiley +1 more source
Anticoagulation in Dilated Cardiomyopathy
Journal of the American College of Cardiology, 1998 Patients with dilated cardiomyopathy have multiple factors that predispose to thromboembolic events. However, reports of the incidence of thromboembolic events in this population vary widely. There has never been a controlled study of long-term anticoagulation among patients with congestive heart failure due to dilated cardiomyopathy. In this report we
Koniaris, Lauren S, Goldhaber, Samuel Z
openaire +2 more sources
Medical treatment of the patients with dilated cardiomyopathy.
, 2019 Medical treatment of the patients with dilated cardiomyopathy.
Luis Martínez-Dolz (331425) +7 more
core +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger +15 more
wiley +1 more source
Coronary artery disease and dilated cardiomyopathy: where parallel universes merge [PDF]
Coronary artery disease and dilated cardiomyopathy: where parallel universes ...
Sinagra, Gianfranco +2 more
core +1 more source
Apoptosis in dilated cardiomyopathy [PDF]
, 2000 Cardiomyopathy, a popular diagnosis that always obscures more than it reveals, nevertheless has several characteristic histological features. These prominently include widespread focal myocardial fibrosis and associated hypertrophy of surviving cardiac ...
강석민
core +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li +12 more
wiley +1 more source
Acta Biomedica Scientifica, 2012 The aim. was to study peculiarities of ischemic and idiopathic dilated cardiomyopathy and. aggregative activity of thrombocytes and. also the response to the therapy by beta-blockers (Atenolol and Bisoprolol). Material and.
P. N. Isakhanova, Yu. N. Ziyaev
doaj